Latest News and Press Releases

Pixium Vision announces participation in investor conferences in November and December 2022 Paris, France, November 15, 2022 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641;...

       Pixium Vision annonce sa position de trésorerie au 30 septembre 2022 et fait le point sur ses activités Paris, 21 octobre 2022 – 7 h 00 CET – Pixium Vision SA (Euronext Growth Paris...

      Pixium Vision announces its cash position at 30 September 2022 and provides an update on its activities Paris, 21 October 2022 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris -...

Pixium Vision annonce la publication dans le Journal of Neural Engineering de données cliniques évaluées par des pairs portant sur l’efficacité du Système Prima chez des patients atteints de DMLA...

Pixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineering Distance between the implant and the target cells was stable...

Pixium Vision annonce sa participation à plusieurs conférences et événements destinés aux investisseurs au mois d’octobre 2022 Paris, France, 4 octobre 2022 - 07h00 CET- Pixium Vision SA (Euronext...

Pixium Vision announces participation in investor conferences and events in October 2022 Paris, France, October 4, 2022 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo:...

Pixium Vision organise une soirée portes ouvertesdestinée aux investisseurs, le 13 octobre 2022, à partir de 17 heures Inscription obligatoire – nombre de places limité Paris, France, 21...

Pixium Vision to host open house eventfor investors on October 13th 2022 from 5 pm Registration needed – Limited availability Paris, France, September 21, 2022 – 07:00 CET – Pixium Vision SA...

Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022 The target number of 38 patients have been...